Gara Jalqabaatti › Saree Oljoo › Colorado › Aurora
Qorannoo klinikaalii Saree Oljoo Aurora, CO keessatti
Qorannoo 28 Saree Oljoo f Aurora fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- University of Colorado, Aurora
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Rocky Mountain Regional VA Medical Center, Aurora
- UCHealth University of Colorado Hospital, Aurora
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Colorado Denver - School of Medicine - Anschutz Medical Campus, Aurora
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Namoota walitti qabaa jiraSadarkaa 2
- University of Colorado School of Medicine, Aurora
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Namoota walitti qabaa jiraSadarkaa 3
- University of Colorado Anschutz Medical Campus ( Site 0061), Aurora
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Aurora
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Namoota walitti qabaa jiraSadarkaa 3
- University of Colorado Anschutz Medical Campus, Aurora
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Clinical Trial Site, Aurora
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Namoota walitti qabaa jiraSadarkaa 1
- University of Colorado Cancer Center, Aurora
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
Namoota walitti qabaa jiraSadarkaa 1
- Outpatient CTRC, Aurora
- University of Colorado Cancer Center, Aurora
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Namoota walitti qabaa jiraSadarkaa 3
- UCHealth University of Colorado Hospital, Aurora
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Namoota walitti qabaa jiraSadarkaa 2
- University Of Colorado Hospital - Anschutz Cancer Pavilion, Aurora
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Namoota walitti qabaa jiraSadarkaa 2/3
- Local Institution - 0289, Aurora
E-Mindfulness Approaches for Living After Breast Cancer
Namoota walitti qabaa jiraSadarkaa 3
- UCHealth University of Colorado Hospital, Aurora
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Colorado Cancer Center, Aurora
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Colorado Anschutz Medical Campus ( Site 0057), Aurora
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Namoota walitti qabaa jiraSadarkaa 2
- University of Colorado Cancer Center, Aurora
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Namoota walitti qabaa jiraSadarkaa 3
- Rocky Mountain Cancer Centers LLP, Aurora
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Namoota walitti qabaa jiraSadarkaa 3
- UCHealth University of Colorado Hospital, Aurora
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Namoota walitti qabaa jiraQorannoo ilaalaa
- Rocky Mountain Cancer Centers-Aurora, Aurora
Improving Care for Rural Patients With Solid Tumors
Namoota walitti qabaa jira
- University of Colorado Hospital, Aurora
Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors
Namoota walitti qabaa jiraSadarkaa 2
- University of Colorado Anschutz Medical Campus, Aurora
The Immune System's Response to Young Women's Breast Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of Colorado Denver, Aurora
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Namoota walitti qabaa jiraQorannoo ilaalaa
- UCHealth Cancer Care - Anschutz Medical Campus - University of Colorado Cancer Center, Aurora
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Aurora
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Namoota walitti qabaa jiraQorannoo ilaalaa
- Rocky Mountain Cancer Centers, Aurora
- University of Colorado Cancer Center, Aurora
CtDNA Based MRD Testing for NAC Monitoring in TNBC
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of Colorado Cancer Center, Aurora
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
Namoota walitti qabaa jiraSadarkaa 3
- Rocky Mountain Cancer Centers - Aurora, Aurora
Qorannoo Saree Oljoo magaalota biroo keessatti
- New York City, NYQorannoo 136
- Houston, TXQorannoo 126
- Boston, MAQorannoo 112
- Nashville, TNQorannoo 81
- Los Angeles, CAQorannoo 73
- Edison, NJQorannoo 68
- St. Louis, MOQorannoo 64
- Queens, NYQorannoo 64
- Durham, NCQorannoo 64
- Chicago, ILQorannoo 59
- Philadelphia, PAQorannoo 56
- Dallas, TXQorannoo 55
Qorannoo biroo Aurora keessatti
- Saree (Gosoota Hunda)Qorannoo 35
- Kansarii ColorectalQorannoo 32
- Kansara Qara'a Non-Small CellQorannoo 31
- Kansarii OvariiQorannoo 25
- Kansara MetastatikiiQorannoo 25
- Diabetes Type 1Qorannoo 23
- ObesityQorannoo 22
- Kansarii ProstateQorannoo 19
- Dhibee QaraQorannoo 19
- Cufama OnneeQorannoo 18
- MelanomaQorannoo 18
- Leukemia Myeloidii HamaaQorannoo 16
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.